Wegovy - the semaglutide-based injection and pill approved specifically for weight management - is one of the most studied drugs in this class
t 14.2 =3.12, P=0.007), histone H3-3B (t 12.5 =3.43, P=0.005), high mobility group nucleosome-binding domain-containing protein 2 (HMGN2
Regular follow-ups with a healthcare provider will help track improvements in attention, behavior, and eating patterns
Its anti-inflammatory effects, impact on immune regulation, and ability to promote weight loss all suggest it could be beneficial for people with nasal allergies
When evaluating providers, ask whether they offer both semaglutide and tirzepatide, what their protocol is for switching between medications, and whether their clinical team has experience managing patients on multiple GLP-1 platforms